To reduce number of adverse events 2020 American College of Rheumatology Guideline for the Management of Gout to use colchicine in low dosages14.
Low dose regimen of colchicine leads considerably
improved safety profile
With the new low dose regimen side effects are dramatically
reduced and the treatment is much better tolerated!
Incidence of most frequent adverse events15
With low dose colchicine the incidence of severe diarrhea
is significantly reduced to level closed as placebo!
CI – Confidence interval
Comparative effectiveness of low dose vs high dose colchicine15
Improved pain patients with ≥ 50% reduction in pain after 24 hours
Low dose colchicine was as effective as high dose colchicine, but with a safety profile comparable to thatof a placebo.
Acute gout flare onset requires therapy initiation within 12 hours.
Advantages of low dose colchicine therapy:
Learn more about the 2020 American College of Rheumatology Guideline for the Management of Gout
Click here